Dogwood Therapeutics, Inc. (DWTX) vs OKYO Pharma Limited (OKYO)
A side-by-side comparison of Dogwood Therapeutics, Inc. and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DWTX
Dogwood Therapeutics, Inc.
$1.56HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
OKYO
OKYO Pharma Limited
$1.49HealthcareDelayed quote: Oct 6, 2026, 1:51 PM EDT
Total return — DWTX vs OKYO
growth of $100 · dividends reinvested · last 4yDWTX -98.4% (-64.6%/yr)OKYO -59.4% (-20.2%/yr)OKYO compounded faster over this window
Log scale — wide-divergence pair
DWTX OKYO
DWTX vs OKYO: by the numbers
- •OKYO is the larger company ($57M vs $52M market cap).
Metrics side by side
Valuation
| Metric | DWTX | OKYO |
|---|---|---|
| P/B ratio | 0.77 | 4.62 |
Profitability
| Metric | DWTX | OKYO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -52.72% | -72.55% |
| ROIC | -38.04% | -68.91% |
Growth (annualized)
| Metric | DWTX | OKYO |
|---|---|---|
| Total return CAGR (5Y) | -58.44% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.